Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jeffrey E. Young currently holds 25,000 shares of Biostage, Inc. (BSTG), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeffrey E. Young has been a net buyer of BSTG stock. They have purchased $45.9K and sold $0 worth of shares.
Jeffrey E. Young's most recent insider trade was on Sep 30, 2019, when they sold 25,000 shares at $2.00 per share.
Jeffrey E. Young serves as Executive at Biostage, Inc. (BSTG). They have executed 14 insider transactions totaling $45.9K over their tenure at the company.
Jeffrey E. Young holds the position of Executive at Biostage, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Jeffrey E. Young has shown a buying trading pattern, with $45.9K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Jeffrey E. Young was on Dec 27, 2006, when they purchased $712.9K worth of CRTX shares. This transaction involved 26,700 shares at $26.70 per share.
Jeffrey E. Young currently owns 25,000 shares of Biostage, Inc. (BSTG), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jeffrey E. Young's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jeffrey E. Young has 14 Form 4 filings on record as an insider at Biostage, Inc..
Set alerts for Jeffrey E. Young and 40,000+ other insiders.